[Case of adult T-cell leukemia with massive intestinal involvement presenting severe diarrhea as chief symptom]

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

ESMO open·2022

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib.

ESMO open·2021

A validation study of combined resection and ablation therapy for multiple hepatocellular carcinoma.

Clinical radiology·2021

Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma.

ESMO open·2021

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.

Journal of viral hepatitis·2016

Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma.

International journal of laboratory hematology·2008

[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Complement-coagulation crosstalk in immunothrombosis].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

One Health tick bite exposure biomarkers against Ixodes ricinus salivary peptides.

Research square·2026

Lung Resident T Cells Across the Spectrum of TB Infection and Disease.

bioRxiv : the preprint server for biology·2026

Biomarker discrepancies following chimeric antigen receptor T cells: implications in B-cell acute lymphoblastic leukemia.

Haematologica·2026

Surgical outcomes following intradural extramedullary spinal tumour resection - a single centre retrospective review.

British journal of neurosurgery·2026

Heterogeneity and ontogeny of mouse thymic macrophages reveal a requirement for Csf1r-expressing myeloid cells during early T cell development.

eLife·2026

BCMA-Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management.

European journal of haematology·2026

Related Experiment Videos

[Case of adult T-cell leukemia with massive intestinal involvement presenting severe diarrhea as chief symptom]

Related Concept Videos

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib.

A validation study of combined resection and ablation therapy for multiple hepatocellular carcinoma.

Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma.

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.

Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma.

[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

[Complement-coagulation crosstalk in immunothrombosis].

One Health tick bite exposure biomarkers against Ixodes ricinus salivary peptides.

Lung Resident T Cells Across the Spectrum of TB Infection and Disease.

Biomarker discrepancies following chimeric antigen receptor T cells: implications in B-cell acute lymphoblastic leukemia.

Surgical outcomes following intradural extramedullary spinal tumour resection - a single centre retrospective review.

Heterogeneity and ontogeny of mouse thymic macrophages reveal a requirement for Csf1r-expressing myeloid cells during early T cell development.

BCMA-Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management.

Related Experiment Videos

[Case of adult T-cell leukemia with massive intestinal involvement presenting severe diarrhea as chief symptom]

Related Concept Videos

Related Articles